Indivior Pharmaceuticals, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 13G, Stake over 5%, passiveSep 30 →Insiders6 insiders bought $203,601 in 8 open-market buys. 2 insiders sold $2.1M, all 2 sales on a 10b5-1 plan.→HoldersBlackRock 15.9%Vanguard Portfolio 6.4%Oaktree 5.2%→PeersClosest companies: AXSM, XERS, AMPH→
From the filings
Figures
- Revenue
- $1.33Blast 12 months
- Net income
- $355.0Mlast 12 months
- Operating cash flow
- −$111.0Mlast 12 months
- Cash and equivalents
- $222.0Mat the last balance sheet
- Total debt
- $487.0Mat the last balance sheet
- Shares outstanding
- 118.0M shareson issue